Xponance, Inc. Exelixis, Inc. Transaction History

Xponance, Inc.

$10.2 Billion
Q3 2024

A detailed history of Xponance, Inc. transactions in Exelixis, Inc. stock. As of the latest transaction made, Xponance, Inc. holds 61,245 shares of EXEL stock, worth $2.18 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

61,245

Previous 59,484 2.96%

Holding current value

$2.18 Million

Previous $1.34 Million 18.94%

% of portfolio

0.02%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$21.96 - $27.6 $38,671 - $48,603	1,761 Added 2.96%	61,245 $1.59 Million
Q2 2024 Aug 14, 2024	SELL	$20.34 - $23.73 $66,491 - $77,573	-3,269 Reduced 5.21%	59,484 $1.34 Million
Q1 2024 May 13, 2024	SELL	$20.17 - $23.93 $51,736 - $61,380	-2,565 Reduced 3.93%	62,753 $1.49 Million
Q4 2023 Jan 31, 2024	SELL	$19.25 - $24.13 $66,489 - $83,345	-3,454 Reduced 5.02%	65,318 $1.57 Million
Q3 2023 Oct 23, 2023	SELL	$19.04 - $22.74 $18,354 - $21,921	-964 Reduced 1.38%	68,772 $1.5 Million
Q2 2023 Jul 13, 2023	SELL	$18.17 - $20.48 $25,583 - $28,835	-1,408 Reduced 1.98%	69,736 $1.33 Million
Q1 2023 Apr 17, 2023	BUY	$16.3 - $19.41 $8,508 - $10,132	522 Added 0.74%	71,144 $1.38 Million
Q4 2022 Jan 23, 2023	BUY	$14.96 - $17.39 $89,909 - $104,513	6,010 Added 9.3%	70,622 $0
Q3 2022 Oct 24, 2022	SELL	$15.68 - $22.27 $7,573 - $10,756	-483 Reduced 0.74%	64,612 $1.01 Million
Q2 2022 Aug 02, 2022	BUY	$17.44 - $23.16 $63,446 - $84,256	3,638 Added 5.92%	65,095 $1.36 Million
Q1 2022 Apr 20, 2022	SELL	$17.03 - $22.67 $17,932 - $23,871	-1,053 Reduced 1.68%	61,457 $1.39 Million
Q4 2021 Jan 31, 2022	BUY	$15.84 - $21.88 $5,686 - $7,854	359 Added 0.58%	62,510 $1.14 Million
Q3 2021 Nov 05, 2021	SELL	$16.3 - $21.14 $20,016 - $25,959	-1,228 Reduced 1.94%	62,151 $1.31 Million
Q2 2021 Aug 12, 2021	BUY	$17.95 - $25.56 $345,160 - $491,493	19,229 Added 43.55%	63,379 $1.16 Million
Q1 2021 May 10, 2021	BUY	$20.53 - $25.22 $2,648 - $3,253	129 Added 0.29%	44,150 $997,000
Q4 2020 Feb 11, 2021	BUY	$18.39 - $24.8 $5,590 - $7,539	304 Added 0.7%	44,021 $884,000
Q3 2020 Oct 26, 2020	BUY	$20.67 - $26.94 $100,952 - $131,574	4,884 Added 12.58%	43,717 $1.07 Million
Q2 2020 Aug 14, 2020	BUY	$16.46 - $27.42 $639,191 - $1.06 Million	38,833 New	38,833 $922,000

Others Institutions Holding EXEL

# of Institutions

501

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account